Detection of epigenetic field defects using a weighted epigenetic distance-based method.

Area of Science:

• Epigenetics
• Cancer Biology
• Bioinformatics

Background:

• Early detection of cancer is crucial for effective treatment.
• Epigenetic alterations, specifically DNA methylation changes, are early indicators of cancer.
• Identifying these alterations as 'outlier' patterns across samples is challenging.

Purpose of the Study:

• To develop a novel weighted epigenetic distance method for detecting early cancer signals.
• To improve the identification of infrequent epigenetic field defects.
• To enhance the power of epigenome-wide association studies (EWAS).

Main Methods:

• Developed a weighted epigenetic distance metric comparing methylation patterns between samples.
• Incorporated weights to prioritize informative CpG sites and reduce noise.
• Considered both differential methylation (DM) and differential variability (DV) signals.
• Validated the method using simulation studies and real breast cancer methylation data.

Main Results:

• The weighted epigenetic distance method outperformed non-weighted versions and standard EWAS in simulations.
• The method identified novel epigenetic field defects in breast cancer data that were missed by EWAS.
• Identified defects were associated with breast cancer progression and partially replicated.

Conclusions:

• The weighted epigenetic distance method is a powerful tool for detecting subtle, early epigenetic alterations indicative of cancer.
• This approach enhances the ability to find novel cancer biomarkers.
• The findings support the utility of epigenetic field defects in early cancer detection and prognosis.